Inhibition of SCD1 in cancer cells leads to dephosphorylation and activation of GSK3β, which halts cell proliferation by inducing β-catenin and cyclin D1 ubiquitinylation and degradation (Scaglia and Igal, 2008). The gene discussed is SCD; the disease is cancer.